9 results  1 of 1 

1 Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Alvaro Gregorio Morales Taboada, Pablo Lozano Lominchar, Lorena Martin Roman, Pilar García-Alfonso, Andres Jesús Muñoz Martin, Jose Antonio Blanco Rodriguez, Jose Manuel Asencio Pascual
Ann Hepatobiliary Pancreat Surg.2021;25(2):179-191.   Published online 2021 May 31     DOI: http://dx.doi.org/10.14701/ahbps.2021.25.2.179
      
2 Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to pancreatic cancer?
Dae Wook Hwang, Eun Shin, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon
Ann Hepatobiliary Pancreat Surg.2020;24(2):127-136.   Published online 2020 May 31     DOI: http://dx.doi.org/10.14701/ahbps.2020.24.2.127
      
3 Clinical importance of preoperative and postoperative prognostic nutritional index in patients with pancreatic ductal adenocarcinoma
Masahide Ikeguchi, Keisuke Goto, June Watanabe, Shoichi Urushibara, Tomohiro Osaki, Kanenori Endo, Shigeru Tatebe, Seiichi Nakamura
Ann Hepatobiliary Pancreat Surg.2019;23(4):372-376.   Published online 2019 November 29     DOI: http://dx.doi.org/10.14701/ahbps.2019.23.4.372
      
4 Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinoma
Alexandros Giakoustidis, Kyriakos Neofytou, Mafalda Costa Neves, Dimitrios Giakoustidis, Eleni Louri, David Cunningham, Satvinder Mudan
Ann Hepatobiliary Pancreat Surg.2018;22(3):197-207.   Published online 2018 August 31     DOI: http://dx.doi.org/10.14701/ahbps.2018.22.3.197
      
5 Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma
Hye Jin Kim, Mi-Suk Park, Jin Yong Lee, Kyunghwa Han, Yong Eun Chung, Jin-Young Choi, Myeong-Jin Kim, Chang Moo Kang
Cancer Res Treat.2019;51(1):24-33.   Published online 2018 February 5     DOI: http://dx.doi.org/10.4143/crt.2017.404
      
6 Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes Cell Proliferation and Motility in Pancreatic Cancer
Shu-qian Wang, Yu Liu, Min-ya Yao, Jing Jin
J Korean Med Sci.2016;31(10):1586-1594.   Published online 2016 August 19     DOI: http://dx.doi.org/10.3346/jkms.2016.31.10.1586
      
7 Intraductal Carcinoma of the Prostate Gland: Recent Advances
Mukul K. Divatia, Jae Y. Ro
Yonsei Med J.2016;57(5):1054-1062.   Published online 2016 June 30     DOI: http://dx.doi.org/10.3349/ymj.2016.57.5.1054
      
8 Differentiating Pancreatic Ductal Adenocarcinoma from Pancreatic Serous Cystadenoma, Mucinous Cystadenoma, and a Pseudocyst with Detailed Analysis of Cystic Features on CT Scans: a Preliminary Study
Peijie Lv, Radfan Mahyoub, Xiaozhu Lin, Kemin Chen, Weimin Chai, Jing Xie
Korean J Radiol.2011;12(2):187-195.   Published online 2011 March 3     DOI: http://dx.doi.org/10.3348/kjr.2011.12.2.187
      
9 Role of Exocrine Pancreatic Progenitor Cells in Pancreatic Carcinogenesis
Si Young Song
Yonsei Med J.2004;45(Suppl):S74A7-S75A7.   Published online 2009 April 7     DOI: http://dx.doi.org/10.3349/ymj.2004.45.Suppl.74A7
      

 1 of 1